Predicting Generalization of AI Colonoscopy Models to Unseen Data
Authors:
Joel Shor,
Carson McNeil,
Yotam Intrator,
Joseph R Ledsam,
Hiro-o Yamano,
Daisuke Tsurumaru,
Hiroki Kayama,
Atsushi Hamabe,
Koji Ando,
Mitsuhiko Ota,
Haruei Ogino,
Hiroshi Nakase,
Kaho Kobayashi,
Masaaki Miyo,
Eiji Oki,
Ichiro Takemasa,
Ehud Rivlin,
Roman Goldenberg
Abstract:
$\textbf{Background}$: Generalizability of AI colonoscopy algorithms is important for wider adoption in clinical practice. However, current techniques for evaluating performance on unseen data require expensive and time-intensive labels.
$\textbf{Methods}…
▽ More
$\textbf{Background}$: Generalizability of AI colonoscopy algorithms is important for wider adoption in clinical practice. However, current techniques for evaluating performance on unseen data require expensive and time-intensive labels.
$\textbf{Methods}$: We use a "Masked Siamese Network" (MSN) to identify novel phenomena in unseen data and predict polyp detector performance. MSN is trained to predict masked out regions of polyp images, without any labels. We test MSN's ability to be trained on data only from Israel and detect unseen techniques, narrow-band imaging (NBI) and chromendoscoy (CE), on colonoscopes from Japan (354 videos, 128 hours). We also test MSN's ability to predict performance of Computer Aided Detection (CADe) of polyps on colonoscopies from both countries, even though MSN is not trained on data from Japan.
$\textbf{Results}$: MSN correctly identifies NBI and CE as less similar to Israel whitelight than Japan whitelight (bootstrapped z-test, |z| > 496, p < 10^-8 for both) using the label-free Frechet distance. MSN detects NBI with 99% accuracy, predicts CE better than our heuristic (90% vs 79% accuracy) despite being trained only on whitelight, and is the only method that is robust to noisy labels. MSN predicts CADe polyp detector performance on in-domain Israel and out-of-domain Japan colonoscopies (r=0.79, 0.37 respectively). With few examples of Japan detector performance to train on, MSN prediction of Japan performance improves (r=0.56).
$\textbf{Conclusion}$: Our technique can identify distribution shifts in clinical data and can predict CADe detector performance on unseen data, without labels. Our self-supervised approach can aid in detecting when data in practice is different from training, such as between hospitals or data has meaningfully shifted from training. MSN has potential for application to medical image domains beyond colonoscopy.
△ Less
Submitted 22 March, 2024; v1 submitted 14 March, 2024;
originally announced March 2024.
Clinical BERTScore: An Improved Measure of Automatic Speech Recognition Performance in Clinical Settings
Authors:
Joel Shor,
Ruyue Agnes Bi,
Subhashini Venugopalan,
Steven Ibara,
Roman Goldenberg,
Ehud Rivlin
Abstract:
Automatic Speech Recognition (ASR) in medical contexts has the potential to save time, cut costs, increase report accuracy, and reduce physician burnout. However, the healthcare industry has been slower to adopt this technology, in part due to the importance of avoiding medically-relevant transcription mistakes. In this work, we present the Clinical BERTScore (CBERTScore), an ASR metric that penal…
▽ More
Automatic Speech Recognition (ASR) in medical contexts has the potential to save time, cut costs, increase report accuracy, and reduce physician burnout. However, the healthcare industry has been slower to adopt this technology, in part due to the importance of avoiding medically-relevant transcription mistakes. In this work, we present the Clinical BERTScore (CBERTScore), an ASR metric that penalizes clinically-relevant mistakes more than others. We demonstrate that this metric more closely aligns with clinician preferences on medical sentences as compared to other metrics (WER, BLUE, METEOR, etc), sometimes by wide margins. We collect a benchmark of 18 clinician preferences on 149 realistic medical sentences called the Clinician Transcript Preference benchmark (CTP) and make it publicly available for the community to further develop clinically-aware ASR metrics. To our knowledge, this is the first public dataset of its kind. We demonstrate that CBERTScore more closely matches what clinicians prefer.
△ Less
Submitted 28 April, 2023; v1 submitted 10 March, 2023;
originally announced March 2023.
